Results 81 to 90 of about 1,361 (189)
Origin of phase relative stability and phase transformation in an S‐ibuprofen–nicotinamide cocrystal
The crystal structure of the metastable form of S‐ibuprofen–nicotinamide cocrystals was solved from powder X‐ray diffraction data and explains the main mechanisms responsible for the relative stability of the two forms of the cocrystals. This also made it possible to explain the transition mechanism between the two forms with temperature.The crystal ...
Mathieu Guerain +7 more
wiley +1 more source
The poor aqueous solubility of many modern active pharmaceutical ingredients (APIs) can severely limit bioavailability. Cocrystals are emerging as a promising means of overcoming this limitation.
Jiatao Li +5 more
core +2 more sources
A new application of quantitative chemometric models (principal component regression and partial least‐squares regression) to powder X‐ray diffraction data is tested. The approach allows evaluation of the relative composition of solid solutions via the characteristic profile shift.
Laura Macchietti +4 more
wiley +1 more source
Preparation and Characterization of Carbamazepine Cocrystal in Polymer Solution
In this study, we attempted to prepare carbamazepine (CBZ) cocrystal through the solution method in ethanol-water solvent mixture (volume ratio 1:1) and polyvinyl pyrrolidone (PVP) solution.
Hao Zhang +4 more
doaj +1 more source
Growing Interest in Pharmaceutical Cocrystals: A Comprehensive Review of Applications and Trends
Cocrystallization of an Active Pharmaceutical Ingredient (API) with a suitable coformer enables the development of multicomponent crystalline systems through green, cost‐effective methods. These cocrystals can enhance key physicochemical and biopharmaceutical properties. Abstract The synthesis of cocrystals stands as a promising and compelling strategy
Sandra Barbosa Neder Agostini +3 more
wiley +1 more source
Efficient Screening of Coformers for Active Pharmaceutical Ingredient Cocrystallization
Controlling the physical properties of solid forms for active pharmaceutical ingredients (APIs) through cocrystallization is an important part of drug product development.
Constantinos C. Pantelides (1356237) +4 more
core +1 more source
It is demonstrated that a combination of mechanochemistry and accelerated aging can be used to synthesize Hydrogen‐bonded Organic Framework (HOF) biocomposites. The vapor‐induced growth enhances enzyme loading, ensures a more homogeneous enzyme distribution, and improves protective properties due to distinct growth mechanisms and kinetics.
Michael R. Hafner +8 more
wiley +1 more source
Five CT cocrystals using TFBQ and fused, polycyclic donors derived from fluorene are synthesized. The π‐stacking in all cocrystals provides a platform for the displaying of in‐plane molecular motions of TFBQ, which is by supramolecular interactions.
Armando Navarro‐Huerta +7 more
wiley +1 more source
Four novel xanthohumol (XN) cocrystals with pharmaceutically acceptable coformers, such as nicotinamide (NIC), glutarimide (GA), acetamide (AC), and caffeine (CF) in the 1:1 stoichiometry were obtained by the slow evaporation solution growth technique ...
Iwona Budziak +2 more
doaj +1 more source
In the search for new active pharmaceutical ingredients, the precise control of the chemistry of cocrystals becomes essential. One crucial step within this chemistry is proton migration between cocrystal coformers to form a salt, usually anticipated by ...
Ewa Patyk-Kaźmierczak +6 more
doaj +1 more source

